Pattern of care for re-irradiation in locally recurrent rectal cancer: a national survey on behalf of the AIRO gastrointestinal tumors study group.

AIRO gastrointestinal tumors study group National survey Re-irradiation Rectal cancer Recurrence

Journal

La Radiologia medica
ISSN: 1826-6983
Titre abrégé: Radiol Med
Pays: Italy
ID NLM: 0177625

Informations de publication

Date de publication:
Jul 2023
Historique:
received: 19 12 2022
accepted: 25 05 2023
medline: 5 7 2023
pubmed: 27 6 2023
entrez: 26 6 2023
Statut: ppublish

Résumé

Radical resection (R0) represents the best curative treatment for local recurrence (LR) rectal cancer. Re-irradiation (re-RT) can increase the rate of R0 resection. Currently, there is a lack of guidelines on Re-RT for LR rectal cancer. The Italian Association of Radiation and clinical oncology for gastrointestinal tumors (AIRO-GI) study group released a national survey to investigate the current clinical practice of external beam radiation therapy in these patients. In February 2021, the survey was designed and distributed to members of the GI working group. The questionnaire consisted of 40 questions regarding center characteristics, clinical indications, doses, and treatment techniques of re-RT for LR rectal cancer. A total of 37 questionnaires were collected. Re-RT was reported as an option for neoadjuvant treatment in resectable and unresectable disease by 55% and 75% of respondents, respectively. Long-course treatment with 30-40 Gy (1.8-2 Gy/die, 1.2 Gy bid) and hypofractionated regimen of 30-35 Gy in 5 fractions were used in most centers. A total dose of 90-100 Gy as EqD2 dose (α/β = 5 Gy) was delivered by 46% of the respondents considering the previous treatment. Modern conformal techniques and daily image-guided radiation therapy protocols were used in 94% of centers. Our survey showed that re-RT treatment is performed with advanced technology that allow a good management of LR rectal cancer. Significant variations were observed in terms of dose and fractionation, highlighting the need for a consensus on a common treatment strategy that could be validated in prospective studies.

Identifiants

pubmed: 37365381
doi: 10.1007/s11547-023-01652-3
pii: 10.1007/s11547-023-01652-3
pmc: PMC10317862
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

869-876

Informations de copyright

© 2023. The Author(s).

Références

Int J Radiat Oncol Biol Phys. 2006 Mar 15;64(4):1129-39
pubmed: 16414206
Radiother Oncol. 2014 Nov;113(2):151-7
pubmed: 25613395
Technol Cancer Res Treat. 2012 Dec;11(6):591-7
pubmed: 22568625
BJS Open. 2021 May 7;5(3):
pubmed: 34089596
Ann Surg. 2023 Jan 20;:
pubmed: 36661037
Int J Radiat Oncol Biol Phys. 2009 Dec 1;75(5):1444-9
pubmed: 19395199
Am J Clin Oncol. 2006 Jun;29(3):219-24
pubmed: 16755173
J Clin Oncol. 2012 Nov 1;30(31):3827-33
pubmed: 23008301
Br J Surg. 2006 Oct;93(10):1215-23
pubmed: 16983741
Colorectal Dis. 2003 Sep;5(5):501-3
pubmed: 12925089
Dis Colon Rectum. 1996 Jul;39(7):730-6
pubmed: 8674362
Front Oncol. 2019 Jun 19;9:529
pubmed: 31275858
Ann Surg Oncol. 2010 May;17(5):1343-56
pubmed: 20041351
N Engl J Med. 2004 Oct 21;351(17):1731-40
pubmed: 15496622
Radiother Oncol. 2017 Jan;122(1):146-151
pubmed: 28057329
J Clin Oncol. 2008 Aug 1;26(22):3687-94
pubmed: 18669453
BJS Open. 2021 May 7;5(3):
pubmed: 33963369
Radiother Oncol. 2015 Mar;114(3):302-9
pubmed: 25716096
Lancet. 1986 Jun 28;1(8496):1479-82
pubmed: 2425199
Radiother Oncol. 2019 Nov;140:10-19
pubmed: 31176204
J Surg Oncol. 2020 Aug;122(2):350-359
pubmed: 32424824
Ann Surg Oncol. 2022 Jan;29(1):99-106
pubmed: 34664141
J Med Internet Res. 2004 Sep 29;6(3):e34
pubmed: 15471760
Surg Oncol. 1995;4(6):283-93
pubmed: 8809950
N Engl J Med. 2006 Sep 14;355(11):1114-23
pubmed: 16971718
Dis Colon Rectum. 2004 Oct;47(10):1599-606
pubmed: 15540287
World J Gastroenterol. 2017 Jun 21;23(23):4170-4180
pubmed: 28694657
Lancet Oncol. 2017 Mar;18(3):336-346
pubmed: 28190762
Lancet Oncol. 2014 Jan;15(1):23-34
pubmed: 24314615
Adv Radiat Oncol. 2021 Oct 27;7(2):100840
pubmed: 35146215
J Clin Oncol. 2006 Oct 1;24(28):4620-5
pubmed: 17008704
N Engl J Med. 2001 Aug 30;345(9):638-46
pubmed: 11547717
Radiother Oncol. 1995 Mar;34(3):185-94
pubmed: 7543209
Dis Colon Rectum. 2015 Jul;58(7):677-85
pubmed: 26200682

Auteurs

Giovanna Mantello (G)

Radiotherapy Department, Azienda Ospedaliero Universitaria delle Marche, Via Conca 71, 60126, Ancona, Italy.

Elena Galofaro (E)

Radiotherapy Department, Azienda Ospedaliero Universitaria delle Marche, Via Conca 71, 60126, Ancona, Italy. elena.galofaro@ospedaliriuniti.marche.it.

Luciana Caravatta (L)

Department of Radiation Oncology, SS Annunziata Hospital, Chieti, Italy.

Clelia Di Carlo (C)

Radiotherapy Department, Azienda Ospedaliero Universitaria delle Marche, Via Conca 71, 60126, Ancona, Italy.

Sabrina Montrone (S)

Department of Radiotherapy, Pisa University, Pisa, Italy.

Donatella Arpa (D)

IRCCS Istituto Scientifico Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Radiotherapy Unit, Meldola, Italy.

Giuditta Chiloiro (G)

Departments of Radiation Oncology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.

Antonino De Paoli (A)

Division of Radiation Oncology, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy.

Vittorio Donato (V)

Radiation Oncology Division, Oncology and Speciality Medicine Department, San Camillo-Forlanini Hospital, Rome, Italy.

Maria Antonietta Gambacorta (MA)

Departments of Radiation Oncology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.

Domenico Genovesi (D)

Department of Radiation Oncology, SS Annunziata Hospital, Chieti, Italy.

Marco Lupattelli (M)

Radiation Oncology Section, University of Perugia and Perugia General Hospital, Perugia, Italy.

Gabriella Macchia (G)

Radiotherapy Unit, Gemelli Molise Hospital, Catholic University of Sacred Heart, Campobasso, Italy.

Giampaolo Montesi (G)

Radiotherapy Unit, ULSS5, Rovigo, Italy.

Rita Marina Niespolo (RM)

Radiotherapy Unit, Azienda Ospedaliera San Gerardo, Monza, Italy.

Elisa Palazzari (E)

Division of Radiation Oncology, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy.

Antonio Pontoriero (A)

Radiation Oncology Unit, Department of Biomedical, Dental Science and Morphological and Functional Images, University of Messina, Messina, Italy.

Melissa Scricciolo (M)

UOC di Radioterapia Oncologica Mestre, Ospedale dell'Angelo, Venice, Mestre, Italy.

Francesca Valvo (F)

Fondazione CNAO, National Center of Oncological Hadrontherapy, Pavia, Italy.

Pierfrancesco Franco (P)

Department of Translational Medicine, Department of Radiation Oncology, Maggiore Della Carità University Hospital, University of Eastern Piedmont, Novara, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH